Hyderabad based biotech firm ImmunoGene, with ICMR support, developed a stabilizer compound that keeps vaccines viable at up to 40°C for 60 days. This breakthrough reduces cold chain reliance, especially for rural immunization drives. COVID 19 booster and measles vaccines using this tech are already in pre approval testing. WHO has taken interest for global deployment in low resource nations.
School assembly highlights 4.4 magnitude Jhajjar quake jolting Delhi‑NCR schools
JNU hosts first Indian Knowledge Systems conference with 100+ papers
GST Council Meeting Decisions
State Announces Free College Coaching Program for Underprivileged Students
Nvidia CEO Huang to meet Trump before China trip
